| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.931 | 3 | 1 | 1991 | 2016 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.110 | None | 1.000 | 3 | 1 | 2008 | 2016 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.400 | None | 1.000 | 2 | 1 | 2008 | 2015 | ||||||||
|
mutS homolog 5 | 0.641 | 0.692 | 3.2E-11 |
|
disease | 0.130 | None | 0.833 | 2 | 1 | 2008 | 2017 | ||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2008 | 2016 | |||||||||
|
interferon regulatory factor 5 | 0.489 | 0.731 | 9.0E-03 |
|
disease | 0.700 | None | 0.949 | 2 | 1 | 2005 | 2020 | ||||||||
|
long intergenic non-protein coding RNA 243 | 0.729 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
PBX homeobox 2 | 0.686 | 0.462 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
ATPase H+ transporting V1 subunit G2 | 0.839 | 0.269 | 2.9E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
PX domain containing serine/threonine kinase like | 0.821 | 0.231 | 1.1E-02 |
|
disease | 0.670 | None | 0.875 | 1 | 1 | 2008 | 2015 | ||||||||
|
DNA damage regulated autophagy modulator 1 | 0.678 | 0.385 | 0.23 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
apolipoprotein M | 0.590 | 0.769 | 9.6E-04 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2014 | 2019 | ||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2005 | 2014 | ||||||||
|
surfactant associated 2 | 0.695 | 0.577 | 3.6E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
NFKB inhibitor like 1 | 0.653 | 0.615 | 2.6E-02 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2008 | 2014 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
olfactory receptor family 14 subfamily J member 1 | 0.890 | 0.154 | 1.7E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
mucin 21, cell surface associated | 0.743 | 0.346 | 8.0E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
AF4/FMR2 family member 1 | 0.659 | 0.423 | 0.71 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
MHC class I polypeptide-related sequence B | 0.576 | 0.731 | 4.1E-05 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2012 | 2017 | ||||||||
|
HLA complex group 18 | 0.722 | 0.538 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.200 | None | 0.786 | 1 | 1 | 1993 | 2017 | ||||||||
|
tripartite motif containing 26B, pseudogene | 0.861 | 0.269 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
PHD and ring finger domains 1 | 0.743 | 0.346 | 5.7E-02 |
|
disease | 0.470 | None | 0.875 | 1 | 1 | 2008 | 2012 | ||||||||
|
ring finger protein 5 | 0.716 | 0.538 | 3.7E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 |